FDA Labeling Change for mRNA COVID-19 Vaccines

Eric A. Meyerowitz

doi:10.1001/jama.2025.21752

FDA Labeling Change for mRNA COVID-19 Vaccines

Eric A. Meyerowitz

Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	462-463
Number of pages	2
Journal	JAMA
Volume	335
Issue number	5
DOIs	https://doi.org/10.1001/jama.2025.21752
State	Published - Feb 3 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2025.21752

Cite this

@article{a65d87c2bfed48b2809fe238270837f0,

title = "FDA Labeling Change for mRNA COVID-19 Vaccines",

author = "Meyerowitz, \{Eric A.\}",

year = "2026",

month = feb,

day = "3",

doi = "10.1001/jama.2025.21752",

language = "English (US)",

volume = "335",

pages = "462--463",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - FDA Labeling Change for mRNA COVID-19 Vaccines

AU - Meyerowitz, Eric A.

PY - 2026/2/3

Y1 - 2026/2/3

UR - https://www.scopus.com/pages/publications/105027306195

UR - https://www.scopus.com/pages/publications/105027306195#tab=citedBy

U2 - 10.1001/jama.2025.21752

DO - 10.1001/jama.2025.21752

M3 - Letter

C2 - 41499101

AN - SCOPUS:105027306195

SN - 0098-7484

VL - 335

SP - 462

EP - 463

JO - JAMA

JF - JAMA

IS - 5

ER -

FDA Labeling Change for mRNA COVID-19 Vaccines

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this